Strategic Analysis of the European Markets for Theranostics

Strategic Analysis of the European Markets for Theranostics published by Frost & Sullivan in May, 2009. This report consists of 53 Pages and the price starts from US $ 6500.

Introduction

Abstract

This strategic analysis service provides a detailed analysis of the European theranostics market. An indepth analysis of marketing parameters coupled with competitive factors and strategies for sustained market prevalence are reported.

Table of Contents

1. STRATEGIC ANALYSIS OF THE EUROPEAN MARKETS FOR THERANOSTICS

Overview

• Overview

Research Scope and Methodology

• Research Scope and Methodology

Background and Applications of Theranostics

• Benefits of Theranostics
• Test Categories
• Stakeholder Analysis
• Pharma-diagnostic Convergence
• Opportunities
• Role in Pharmaceutical Industry
• Application in Drug Development Process

Key Industry Challenges and Recommendations

• Industry Challenges

Key Market Dynamics: Drivers and Restraints

• Drivers and Restraints

Key Disease Areas:Role of Theranostics

• Disease Areas

Special Focus:Oncology

• Oncology
• Recent Advances in Cancer Theranostics

Competitive Overview

• Competitive Overview
• Drugs with Companion Tests

Regulatory Scenario : FDA and EMEA Perspective

• Regulatory Scenario

SWOT Analysis

• SWOT Analysis

Conclusion

• Conclusion

Decision Support Database

• Decision Support Database

Key Industry Participants

• Key Industry Participants

Related Reports